Boehringer Ingelheim pursuing health care innovation – new collaboration with Healthrageous, Inc on a digital diabetes self-management program

Tue, 07/10/2012 - 3:25am
Boehringer Ingelheim

Ingelheim, 10 July, 2012 – In future patients with certain diseases, especially chronic ones, should be treated in a more holistic approach beyond drug treatment only. Thus Boehringer Ingelheim is concentrating on new business models and healthcare innovation and just signed a contract with the US company Healthrageous, Inc., a digital health management company.

Both companies will evaluate in a pilot study a lifestyle behavior modification program to improve the health status of people with diabetes Type 2. Study participants will experience a digital technology intervention combining digital coaching and a wireless glucose meter transmitting data to clinical monitors. The Internet-based tool will allow an evaluation of the intervention on changes in lifestyle behaviors, glucose control, additional medical parameters and medication adherence.



Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.